Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enliven Treateutics

20.51
+0.66003.32%
Post-market: 20.510.00000.00%17:43 EDT
Volume:221.18K
Turnover:4.53M
Market Cap:1.01B
PE:-10.84
High:20.79
Open:19.95
Low:19.65
Close:19.85
Loading ...
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 29, 2023

Correspondence

Form CORRESP - Correspondence
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]